Association of Inadvertent 9-Valent Human Papillomavirus Vaccine in Pregnancy With Spontaneous Abortion and Adverse Birth Outcomes

IMPORTANCE: The 9-valent human papillomavirus (9vHPV) vaccine is recommended for individuals through age 26 years and may be administered to women up to age 45 years. Data on 9vHPV vaccine exposures during pregnancy are limited. OBJECTIVE: To evaluate the associations between 9vHPV vaccine exposures...

Descripción completa

Detalles Bibliográficos
Autores principales: Kharbanda, Elyse O., Vazquez-Benitez, Gabriela, DeSilva, Malini B., Naleway, Allison L., Klein, Nicola P., Hechter, Rulin C., Glanz, Jason M., Donahue, James G., Jackson, Lisa A., Sheth, Sangini S., Greenberg, Victoria, Panagiotakopoulos, Lakshmi, Mba-Jonas, Adamma, Lipkind, Heather S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022219/
https://www.ncbi.nlm.nih.gov/pubmed/33818618
http://dx.doi.org/10.1001/jamanetworkopen.2021.4340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8022219/
https://www.ncbi.nlm.nih.gov/pubmed/33818618
http://dx.doi.org/10.1001/jamanetworkopen.2021.4340

Ejemplares similares